STUDY OF TRIBOLOGICAL PROPERTIES OF BIOCOATINGS BY DETONATION SPRAYING METHOD

2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.53360/2788-7995-2026-2(22)-57
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

In this study, bioactive hydroxyapatite coatings were deposited on commercially pure Grade 2 titanium substrates by detonation spraying at different O₂/C₂H₂ ratios in the range of 2.6-3.7. X-ray diffraction analysis confirmed the predominance of the hydroxyapatite phase with partial formation of α-tricalcium phosphate, which is attributed to high temperatures and intense dynamic processes in the detonation jet. The formed coatings exhibit pronounced hydrophobicity, high structural heterogeneity, and a well-developed surface microrelief, promoting improved interaction with bone tissue and accelerated osseointegration. Tribological tests conducted under dry conditions and in Ringer’s solution demonstrated a significant increase in wear resistance compared to uncoated Grade 2 titanium. The best friction characteristics and the lowest wear volume were observed for coatings deposited at O₂/C₂H₂ ratios of 3.0 and 3.3, which is associated with an optimal combination of crystallinity, phase composition, and adhesion strength. Coatings formed under these conditions provide stable tribological behavior in physiological environments. The obtained results confirm the prospects of detonation-sprayed hydroxyapatite for improving the durability, biocompatibility, and operational reliability of titanium implants.